NEW YORK – The buyer of one of the priciest medical office building (MOB) deals in recent months has no history in the MOB arena, nor does it look to be entering the space.
The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE
